Nebokitug: New Hope for Rare Liver Disease PSC
A new monoclonal antibody, Nebokitug, shows promise in treating Primary Sclerosing Cholangitis (PSC), reducing liver inflammation and fibrosis in trials. Could this transform treatment for this rare liver condition? Read more.